Top Markets
#1 Black Phoenix Black Phoenix +350.66%
#2 Islamic Coin Islamic Coin +158.09%
#3 Glidr Glidr +58.56%
#4 Cryptopia Cryptopia +20.42%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.26%
#6 DOVU DOVU +16.40%
#7 Pons Pons +8.78%
#8 stake.link stake.link +8.32%
#9 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +7.32%
#10 COTI COTI +6.82%
Coin of the day
Black Phoenix Black Phoenix
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Biostax Corp. Biostax Corp.

Biostax Corp.

BTAX
Classement en actions #41904
Biostax Corp. is a biopharmaceutical enterprise dedicated to the acquisition,... Biostax Corp. is a biopharmaceutical enterprise dedicated to the acquisition, advancement, and commercialization of various pharmaceutical and biotechnology solutions. A pivotal focus lies on Lodonal, their lead investigational drug candidate, designed as a once-daily immune system modulator aimed at managing both human immunodeficiency virus and acquired immune deficiency syndrome (HIV/AIDS). Beyond this primary drug, their portfolio encompasses several innovative programs. These include a Global Telehealth platform and an early-stage Medtech initiative leveraging blockchain and smart contract technologies to enhance the security and management of prescriptions and electronic health records. Furthermore, Biostax is developing JKB-122, an experimental small molecule that acts as a long-duration toll-like receptor 4 (TLR4) antagonist, intended for the treatment of autoimmune hepatitis, nonalcoholic fatty liver disease (NAFLD), and nonalcoholic steatohepatitis (NASH). Another compound they address is Low Dose Naltrexone, a formula believed to offer immune-modulating advantages pertinent to conditions such as cancer, chronic pain, autoimmune disorders, and anti-aging efforts. The company also pursues development efforts for addressing hyperphosphatemia. Biostax maintains a licensing agreement with Cytocom Inc. and underwent a corporate name change from Immune Therapeutics, Inc. to its current designation in October 2023. The company's operational base is located in Winter Park, Florida.
Prix de l'action
$0.0001
Dernière synchronisation: 2026-08-11
Capitalisation boursière
$7.87K
Changement (1 jour)
0.00%
Changement (1 an)
-50.00%
Pays
US
Échange Biostax Corp. (BTAX)

Catégorie

Healthcare
Historique du prix de l'action pour Biostax Corp. (BTAX)
Prix de clôture le plus élevé : $0.00 le 2026-08-01

Prix de clôture le plus bas : $800.00 le 2010-08-01
Historique du prix de l'action de Biostax Corp. de 2010 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 0.00%
2025 -99.48%
2024 -72.33%
2023 -91.57%
2022 -66.51%
2021 -84.44%
2020 133.16%
2019 19.03%
2018 -61.96%
2017 -73.85%
2016 -72.58%
2015 30.64%
2014 -88.72%
2013 -83.85%
2012 -28.00%
2011 1,648.30%
2010 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.87 33.33%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $873.57 35.10%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.38 7.69%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $263.09 18.09%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -7.34%
KR